2,035
Views
31
CrossRef citations to date
0
Altmetric
Review

Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management

, , , , &
Pages 3141-3150 | Published online: 11 Dec 2018

References

  • SerjeantGRSickle-cell diseaseLancet199735090797257309291916
  • RobertsIde MontalembertMSickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in EuropeHaematologica200792786587117606434
  • BondsDRThree decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotypeBlood Rev20051929911015603913
  • OkpalaILeukocyte adhesion and the pathophysiology of sickle cell diseaseCurr Opin Hematol2006131404416319686
  • NkrumahFKNeequayeJEAnkra-BaduGBone marrow in sickle cell anaemia at time of anaemic crisisArch Dis Child19845965615656742877
  • SerjeantGRCeulaerCDLethbridgeRMorrisJSinghalAThomasPWThe painful crisis of homozygous sickle cell disease: clinical featuresBr J Haematol19948735865917993801
  • BallasSKPain management of sickle cell diseaseHematol Oncol Clin North Am200519578580216214644
  • ThomasVCognitive behavioural therapy in pain management for sickle cell diseaseInt J Palliat Nurs20006943444212388895
  • BerzonRHaysRDShumakerSAInternational use, application and performance of health-related quality of life instrumentsQual Life Res1993263673688161974
  • YawnBPJohn-SowahJManagement of sickle cell disease: recommendations from the 2014 expert panel reportAm Fam Physician201592121069107626760593
  • BrandowAMPanepintoJAClinical interpretation of quantitative sensory testing as a measure of pain sensitivity in patients with sickle cell diseaseJ Pediatr Hematol Oncol201638428829326907660
  • PopeMAlboCKidwellKMEvolution of chronic pain in sickle-cell diseaseBlood2016128221297
  • TawficQAFarisASKausalyaRThe role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell diseaseJ Pain Symptom Manage201447233434023856095
  • NeriCMPestieauSRDarbariDSLow-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell diseasePaediatr Anaesth201323868468923565738
  • AnieKAGreenJCochrane Cystic Fibrosis and Genetic Disorders GroupPsychological therapies for sickle cell disease and painCochrane Database Syst Rev2015327CD001916
  • BallasSKGuptaKAdams-GravesPSickle cell pain: a critical reappraisalBlood2012120183647365622923496
  • WatsonMLucasCHoyAWellsJOxford Handbook of Palliative Care2nd edOxford, UKOxford University Press2009
  • RangHPPharmacology5th edEdinburghChurchill Livingstone2003234
  • BallasSKPathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell diseaseEur J Haematol201595211312325288149
  • JenningsCABobbBTNoreikaDMCoynePJOral ketamine for sickle cell crisis pain refractory to opioidsJ Pain Palliat Care Pharmacother201327215015423692261
  • KueiNPatelNXuHCharacteristics and potential biomarkers for chronic pain in patients with sickle cell diseaseBlood201512623986
  • Graido-GonzalezEDohertyJBergreenEPlasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisisBlood198892725512555
  • KhodorovaAMontmayeurJPStrichartzGEndothelin receptors and painJ Pain200910142819111868
  • NeborDBowersAHardy-DessourcesMDFrequency of pain crises in sickle cell anemia and its relationship with the sympathovagal balance, blood viscosity and inflammationHaematologica201196111589159421750084
  • SmithWRSchererMSickle-cell pain: advances in epidemiology and etiologyHematology Am Soc Hematol Educ Program20102010140941521239827
  • JacobEChanVWHodgeCZeltzerLZurakowskiDSethnaNFSensory and thermal quantitative testing in children with sickle cell diseaseJ Pediatr Hematol Oncol201537318518925014619
  • HollinsMStonerockGLKisaalitaNRJonesSOrringerEGilKMDetecting the emergence of chronic pain in sickle cell diseaseJ Pain Symptom Manage20124361082109322579409
  • WangZJWilkieDJMolokieRNeurobiological mechanisms of pain in sickle cell diseaseHematology Am Soc Hematol Educ Program2010201040340821239826
  • PortenoyRKTreatment of cancer painLancet201137797842236224721704873
  • SchiavenatoMAlvarezOPain assessment during a vaso-occlusive crisis in the pediatric and adolescent patient: rethinking practiceJ Pediatr Oncol Nurs201330524224823850944
  • HicksCLvon BaeyerCLSpaffordPAvan KorlaarIGoodenoughBThe Faces Pain Scale-Revised: toward a common metric in pediatric pain measurementPain200193217318311427329
  • MerkelSVoepel-LewisTShayevitzJRMalviyaSThe FLACC: A behavioral scale for scoring postoperative pain in young childrenPediatr Nursing1997233293297
  • World Health OrganizationCancer for Pain Relief with a Guide to Opioid AvailabilityGeneva, SwitzerlandWorld Health Organization1996
  • PujolLAMontiDAManaging cancer pain with nonpharmacologic and complementary therapiesJ Am Osteopath Assoc200710712 Suppl 7ES15ES2118165373
  • BallasSKManagement of sickle painCurr Opin Hematol1997421041119107526
  • RichardREThe management of sickle cell painCurr Pain Headache Rep200913429529719586593
  • OkomoUMeremikwuMMFluid replacement therapy for acute episodes of pain in people with sickle cell diseaseCochrane Database Syst Rev201266CD005406
  • OsunkwoITangprichaVJames-HerryAProfound vitamin D deficiency in adolescents with sickle cell chronic painJ Investig Med2010582482
  • QuinlanJCarterKAcute pain management in patients with persistent painCurr Opin Support Palliat Care20126218819322406985
  • AnieKASteptoeAPain, mood and opioid medication use in sickle cell diseaseHematol J200341717312692524
  • PayneRPain management in sickle cell anemiaAnesthesiol Clin North America1997152305318
  • VijenthiraAStinsonJFriedmanJBenchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospitalPain Res Manag201217429129622891195
  • YasterMKost-ByerlySMaxwellLGThe management of pain in sickle cell diseasePediatr Clin North Am200047369971010835998
  • DampierCElyEBrodeckiDO’NealPO’NealPHome management of pain in sickle cell disease: a daily diary study in children and adolescentsJ Pediatr Hematol Oncol200224864364712439036
  • SawyerJSickle cell pain management meets technology: Everybody winsAcute Pain20057113
  • ContiCTsoEBrowneBOral morphine protocol for sickle cell crisis painMd Med J199645133358569458
  • NiscolaPSorrentinoFScaramucciLde FabritiisPCianciulliPPain syndromes in sickle cell disease: an updatePain Med200910347048019416438
  • TelferPCriddleJSandellJDaviesFMorrisonIChallandsJIntranasal diamorphine for acute sickle cell painArch Dis Child2009941297998019321506
  • BrookoffDPolomanoRTreating sickle cell pain like cancer painAnn Intern Med199211653643681736768
  • KrishnamurtiLSmith-PackardBGuptaACampbellMGunawardenaSSaladinoRImpact of individualized pain plan on the emergency management of children with sickle cell diseasePediatr Blood Cancer201461101747175324962217
  • BuchananIDWoodwardMReedGWOpioid selection during sickle cell pain crisis and its impact on the development of acute chest syndromePediatr Blood Cancer200545571672415926170
  • QariMHAljaouniSKAlardawiMSReduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trialThromb Haemost200798239239617721622
  • SalehAWHillenHFDuitsAJLevels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapyActa Haematol19991021313710473885
  • BallasSKBausermanRLMcCarthyWFHydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at homeJ Pain Symptom Manage201040687088220864308
  • ColellaMPDe PaulaEVConranNHydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemiaJ Thromb Haemost20121091967197022817333
  • GladwinMTShelhamerJHOgnibeneFPNitric oxide donor properties of hydroxyurea in patients with sickle cell diseaseBr J Haematol2002116243644411841449
  • SparkenbaughEPawlinskiRInterplay between coagulation and vascular inflammation in sickle cell diseaseBr J Haematol2013162131423593937
  • SmithWRBallasSKMcCarthyWFThe association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patientsPain Med201112569770521481164
  • YawnBPJohn-SowahJManagement of sickle cell disease: recommendations from the 2014 expert panel reportAm Fam Physician201592121069107626760593
  • McGannPTWareREHydroxyurea for sickle cell anemia: what have we learned and what questions still remain?Curr Opin Hematol201118315816521372708
  • CannasGPoutrelSThomasXHydroxycarbamine: from an old drug used in malignant hemopathies to a current standard in sickle cell diseaseMediterr J Hematol Infect Dis201791e201701528293403
  • StallworthJRJerrellJMTripathiACost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell diseaseAm J Hematol2010851079579720645429
  • SmithWRBallasSKMccarthyWFThe association between hydroxyurea treatment and pain intensity, analgesic use, and utilization in ambulatory sickle cell anemia patientsPain Med201112569770521481164
  • InoueSKhanIMushtaqRPain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell diseaseAnn Hematol201695222122526611852
  • WoodKCGrangerDNSickle cell disease: role of reactive oxygen and nitrogen metabolitesClin Exp Pharmacol Physiol200734992693217645642
  • GladwinMTKatoGJWeinerDNitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialJAMA2011305989390221364138
  • de FranceschiLMuraPSchweigerVFentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell diseasePain Pract201616668068726009799
  • MallinsonTEA review of ketorolac as a prehospital analgesicJ Paramed Pract2017912522526
  • BrousseauDCScottJPHilleryCAPanepintoJAThe effect of magnesium on length of stay for pediatric sickle cell pain crisisAcad Emerg Med200411996897215347549
  • PowellCKolamunnage-DonaRLoweJMagnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trialLancet Respir Med20131430130824429155
  • DudleyLHenderson-SmartDJWalkerGJChouDMagnesium sulphate versus diazepam for eclampsiaCochrane Database Syst Rev201012CD000127
  • Melzer-LangeMDWalsh-KellyCMLeaGHilleryCAScottJPPatient-controlled analgesia for sickle cell pain crisis in a pediatric emergency departmentPediatr Emerg Care20042012414716157
  • MyersMEckesEJA novel approach to pain management in persons with sickle cell diseaseMedsurg Nurs201221529329823243787
  • ZubrzyckiMLieboldASkrabalCAssessment and pathophysiology of pain in cardiac surgeryJ Pain Res2018111599161130197534
  • BallasSKViscusiEREpsteinKRManagement of acute chest wall sickle cell pain with nebulized morphineAm J Hematol200476219019115164390
  • ShahNRollinsMLandiDShahRBaeJde CastroLMDifferences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisisClin J Pain201430326626823669451
  • WilsonBHNelsonJSickle cell disease pain management in adolescents: a literature reviewPain Manag Nurs201516214615125175555
  • EnderKLKrajewskiJABabineauJUse of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell diseasePediatr Blood Cancer201461469369624249617
  • JacobEThe pain experience of patients with sickle cell anemiaPain Manag Nurs200123748311710089
  • EdwardsLYEdwardsCLPsychosocial treatments in pain management of sickle cell diseaseJ Natl Med Assoc2010102111084109421141299
  • FieldTABeesonETJonesLKThe New ABCs: a practitioner’s guide to neuroscience-informed cognitive-behavior therapyJ Ment Health Couns2015373206220
  • African Palliative Care AssociationBeating pain: a Pocket-guide for Pain Management in Africa’APCAKampala, Uganda2010 Available from: http://apps.who.int/medicinedocs/documents/s19114en/s19114en.pdfAccessed December 5, 2018